Dickinson Andrew D 4

What Happened
Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences (GILD), sold 3,000 shares on June 15, 2026 at $125.40 per share, for a total value of $376,200. The Form 4 reports this as an open-market or private sale (code S). The filing notes the trade was made pursuant to a Rule 10b5-1 trading plan adopted August 29, 2024—suggesting the sales were pre-scheduled rather than ad hoc.

Key Details

• Transaction date: 2026-06-15; sale price: $125.40; shares sold: 3,000; proceeds ≈ $376,200.
• Report filed: 2026-06-16 (timely filing the day after the transaction).
• Footnote: Trade executed under a Rule 10b5-1 plan adopted 8/29/2024.
• Shares owned after the transaction: not provided in the summary data supplied.
• Transaction type/code: Sale (S); not an option exercise, gift, or award.

Context
Sales under 10b5-1 plans are typically pre-arranged and common for insiders to diversify or meet liquidity needs; they do not necessarily signal a change in the insider’s view of the company. For retail investors, purchases usually carry more informational weight than routine, pre-planned sales. This report is factual and does not establish motivation for the sale.